| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yao-Lin Li, Zhong-Xuan Wang, Chang-Zhou Ying, Bao-Rong Zhang, Jia-Li P. Decoding the Role of Familial Parkinson's Disease-Related Genes in DNA Damage and Repair. Aging and disease. vol 13. issue 5. 2022-10-03. PMID:36186134. |
parkinson's disease (pd) is a neurodegenerative disease characterized by the degeneration of midbrain substantia nigra pars compacta dopaminergic neurons and the formation of lewy bodies. |
2022-10-03 |
2023-08-14 |
Not clear |
| Da Woon Lee, Young-Kyoung Ryu, Dong-Ho Chang, Hye-Yeon Park, Jun Go, So-Young Maeng, Dae Youn Hwang, Byoung-Chan Kim, Chul-Ho Lee, Kyoung-Shim Ki. Journal of microbiology and biotechnology. vol 32. issue 9. 2022-09-28. PMID:36168204. |
parkinson's disease (pd) is the second-most prevalent neurodegenerative disease and is characterized by dopaminergic neuronal death in the midbrain. |
2022-09-28 |
2023-08-14 |
Not clear |
| Unaiza Naeem, Abdul Rehman Arshad, Areesha Jawed, Farea Eqbal, Laiba Imran, Zayeema Khan, Farhat Ija. Glycolysis: The Next Big Breakthrough in Parkinson's Disease. Neurotoxicity research. 2022-09-24. PMID:36152171. |
parkinson's disease (pd) is a common neurodegenerative disease characterized by the death of dopaminergic neurons. |
2022-09-24 |
2023-08-14 |
Not clear |
| Arvie Camille V de Guzman, Seunghun Kang, Eun Ji Kim, Jin Ho Kim, Nari Jang, Joong Hee Cho, Shin Sik Cho. High-Glucose Diet Attenuates the Dopaminergic Neuronal Function in ACS omega. vol 7. issue 36. 2022-09-19. PMID:36120016. |
high-glucose diet attenuates the dopaminergic neuronal function in parkinson's disease (pd) is a neurodegenerative disease characterized by the selective degeneration of neurons, primarily in the substantia nigra. |
2022-09-19 |
2023-08-14 |
Not clear |
| Naomi J Thorne, David A Tumbarell. The relationship of alpha-synuclein to mitochondrial dynamics and quality control. Frontiers in molecular neuroscience. vol 15. 2022-09-12. PMID:36090250. |
mitochondrial dysfunction has been implicated in driving the pathology of several neurodegenerative diseases, including parkinson's disease (pd) where dopaminergic neurons in the substantia nigra are selectively degenerated. |
2022-09-12 |
2023-08-14 |
Not clear |
| Christian Ardianto, Robert Shen, Jimmy F A Barus, Poppy Kristina Sasmita, Yuda Turana, Lilis Lilis, Veronika Maria Sidhart. Secretome as neuropathology-targeted intervention of Parkinson's disease. Regenerative therapy. vol 21. 2022-09-12. PMID:36092507. |
parkinson's disease (pd) is the second most common progressive neurodegenerative disease, characterized by apoptosis of dopaminergic neurons in substansia nigra pars compacta (snpc) caused by ⍺-synuclein aggregation. |
2022-09-12 |
2023-08-14 |
Not clear |
| Puyu Li, Ningdi Luo, Sainan Sun, Yuanyuan Li, Dingding Shen, Xue Zhu, Liche Zhou, Haiyan Zhou, Jun Li. Neuroprotective Effects of Intermittent Theta Burst Stimulation in Parkinson's Disease (NET-PD): A Study Protocol for a Delayed-Start Randomized Double-Blind Sham-Controlled Trial. Journal of clinical medicine. vol 11. issue 17. 2022-09-09. PMID:36078903. |
as a typical high-disability neurodegenerative disease, parkinson's disease (pd) progresses variably, and patients who are clinically insensitive to dopaminergic therapy and whose symptoms fail to improve are commonly observed. |
2022-09-09 |
2023-08-14 |
Not clear |
| Elif Çınar, Banu Cahide Tel, Gürdal Şahi. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities. Balkan medical journal. 2022-08-29. PMID:36036436. |
parkinson's disease (pd) is a complex, chronic, and progressive neurodegenerative disease that is characterized by irreversible dopaminergic neuronal loss in the substantia nigra. |
2022-08-29 |
2023-08-14 |
Not clear |
| Gunjan Thakur, Vikas Kumar, Keun Woo Lee, Chungkil Wo. Structural Insights and Development of LRRK2 Inhibitors for Parkinson's Disease in the Last Decade. Genes. vol 13. issue 8. 2022-08-26. PMID:36011337. |
parkinson's disease (pd) is the second most prevalent neurodegenerative disease, characterized by the specific loss of dopaminergic neurons in the midbrain. |
2022-08-26 |
2023-08-14 |
Not clear |
| Qun Wang, Rui Ma, Piaoxue Liu, Guowang Cheng, Qi Yang, Xiaojia Chen, Zhenfeng Wu, Dongsheng Yuan, Tongkai Che. Efficient Sustained-Release Nanoparticle Delivery System Protects Nigral Neurons in a Toxin Model of Parkinson's Disease. Pharmaceutics. vol 14. issue 8. 2022-08-26. PMID:36015354. |
parkinson's disease (pd) is a serious neurodegenerative disease wherein the progressive destruction of dopaminergic neurons results in a series of related movement disorders. |
2022-08-26 |
2023-08-14 |
Not clear |
| Eulla Keimili Fernandes Ferreira Cavalheiro, Larissa Espindola da Silva, Mariana P Oliveira, Marina G Silva, Adriani P Damiani, Catharina B Ribeiro, Marina L Magenis, Luana Cucker, Monique Michels, Larissa Joaquim, Richard Simon Machado, Thais C Vilela, Rafael M Bitencourt, Vanessa M Andrade, Felipe Dal-Pizzol, Fabrícia Petronilho, Talita Tuon, Gislaine Tezza Rezi. Effects of obesity on neuroinflammatory and neurochemical parameters in an animal model of reserpine-induced Parkinson's disease. Behavioural brain research. 2022-07-25. PMID:35872330. |
it is known that dopaminergic neurotransmission is also reduced in parkinson's disease (pd), and high adiposity is considered a risk factor for the development of several neurodegenerative diseases, including pd. |
2022-07-25 |
2023-08-14 |
Not clear |
| Amrutha K, Amit Mishra, Sarika Sing. Implications of intracellular protein degradation pathways in Parkinson's disease and therapeutics. Journal of neuroscience research. 2022-07-12. PMID:35819247. |
parkinson's disease (pd) pathology is the most common motor neurodegenerative disease that occurs due to the progressive degeneration of dopaminergic neurons of the nigrostriatal pathway of the brain. |
2022-07-12 |
2023-08-14 |
Not clear |
| Xiangjun Yuan, Yanan Wu, Lei Lu, Jie Fen. Long noncoding RNA SNHG14 knockdown exerts a neuroprotective role in MPP Metabolic brain disease. 2022-07-05. PMID:35781593. |
long noncoding rna snhg14 knockdown exerts a neuroprotective role in mpp parkinson's disease (pd) is a neurodegenerative disease resulted from the loss of dopaminergic neurons. |
2022-07-05 |
2023-08-14 |
Not clear |
| Débora F Gonçalves, Tâmie Duarte, João V P Foletto, Leahn R Senger, Nilda Vargas Brabosa, Félix A A Soares, Cristiane L Dalla Cort. Mitochondrial function and cellular energy maintenance during aging in a Drosophila melanogaster model of Parkinson Disease. Mitochondrion. 2022-07-05. PMID:35787469. |
parkinson's disease (pd) is a common neurodegenerative disease characterized by movement disorders as well as loss of dopaminergic neurons. |
2022-07-05 |
2023-08-14 |
drosophila_melanogaster |
| Binlin Xu, Xiaoquan Wang, Zhengshuang Xu, Qinkai Li, Junmin Qua. N-cystaminylbiguanide MC001 prevents neuron cell death and alleviates motor deficits in the MPTP-model of Parkinson's disease. Neuroscience letters. 2022-06-23. PMID:35738458. |
parkinson's disease (pd) is a common neurodegenerative disease characterized by the progressive loss of dopaminergic (da) neurons in the substantia nigra (sn), which is highly associated with oxidative stress. |
2022-06-23 |
2023-08-14 |
mouse |
| Marta Esteves, Ricardo Abreu, Hugo Fernandes, Catarina Serra-Almeida, Patrícia A T Martins, Marta Barão, Ana Clara Cristóvão, Cláudia Saraiva, Raquel Ferreira, Lino Ferreira, Liliana Bernardin. MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson's disease. Molecular therapy : the journal of the American Society of Gene Therapy. 2022-06-11. PMID:35689381. |
parkinson's disease is a neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra with no effective cure available. |
2022-06-11 |
2023-08-14 |
mouse |
| Theodora Mourtzi, Ilias Kazani. Endogenous Neural regeneration research. vol 17. issue 12. 2022-06-06. PMID:35662194. |
endogenous parkinson's disease is the second most common neurodegenerative disease and has currently no effective treatment, one that would be able to stop or reverse the loss of dopaminergic neurons in the substantia nigra pars compacta. |
2022-06-06 |
2023-08-14 |
Not clear |
| Le Zhang, Yingshuang Zhang, Dongsheng Fa. Pathological Role of Natural Killer Cells in Parkinson's Disease: A Systematic Review. Frontiers in aging neuroscience. vol 14. 2022-06-06. PMID:35663564. |
parkinson's disease (pd) is one of the common neurodegenerative diseases that is characterized by selective degeneration of dopaminergic neurons in the substantia nigra, and misfolding of α-synuclein into aggregates is thought to contribute to its pathology. |
2022-06-06 |
2023-08-14 |
Not clear |
| Hung-Te Hsu, Ya-Lan Yang, Wan-Hsuan Chang, Wei-Yu Fang, Shu-Hung Huang, Shah-Hwa Chou, Yi-Ching L. Hyperbaric Oxygen Therapy Improves Parkinson's Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway. Biomolecules. vol 12. issue 5. 2022-05-28. PMID:35625589. |
pd is a neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2022-05-28 |
2023-08-13 |
mouse |
| Sangeun Han, Sabina Lim, Sujung Ye. Association between Decreased ITGA7 Levels and Increased Muscle α-Synuclein in an MPTP-Induced Mouse Model of Parkinson's Disease. International journal of molecular sciences. vol 23. issue 10. 2022-05-28. PMID:35628462. |
parkinson's disease (pd) is a neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra (sn), reducing dopaminergic levels in the striatum and affecting motor control. |
2022-05-28 |
2023-08-13 |
mouse |